Shanghai Xincere Med Tech Inc. is the premier provider of Decentralized Clinical Trial (DCT) platform solutions in China, specializing in the development of a patient-centric intelligent platform tailored for remote clinical trials. Leveraging the application of digital technology in clinical trials, Xincere is committed to enhancing the accessibility of clinical trials, mitigating the burden on patients, elevating the quality and efficiency of clinical studies, and minimizing the cost of drug research and development.

Xincere's business portfolio encompasses a comprehensive suite of solutions: ePData, an integrated electronic Clinical Outcome Assessment (eCOA) solution, Scale Management, Rater Training, eDiary, eConsent, TeleVisit, and more. With its locally compatible integrated eCOA solution, Xincere boasts numerous successful Phase II/III clinical trial projects and has pioneered the application of remote visit solutions in China. Dedicated to advancing digital technology in support of novel drug research and development in China, we aspire to serve patients and contribute positively to society.